Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

NASHNET

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1985-1987.e4
JournalGastroenterology
Volume159
Issue number5
DOIs
StatePublished - Nov 2020

Keywords

  • Cirrhosis
  • Fibrosis
  • High-risk population
  • NASH
  • Screening

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this